Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 8,125 shares at $4.07 ($33K) on 2025-12-31, disclosed to the SEC on 2026-01-05.
Scheduled sale ($33k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2026-06-25 | $24K | — | Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-06 | $465K | — | Filing → |